News Daily News Análisis del Estudio Mesa: Las Imágenes Ateroscleróticas ‘Negativas’ Minimizan el Riesgo de ECV a los 10 Años Michael O'Riordan January 28, 2016
News Features PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data Michael O'Riordan January 25, 2016
News Daily News Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target Michael O'Riordan December 21, 2015
News Daily News Por 1ª Vez unos Estudios asocian las Bacterias Intestinales a la Aterosclerosis y ofrecen una Mirada Asombrosa a una Nueva Diana Farmacológica Michael O'Riordan December 21, 2015
News Daily News ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention Michael O'Riordan December 13, 2015
News Daily News NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication Michael O'Riordan December 08, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015
News Industry News Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab) September 11, 2015
News Industry News Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet July 23, 2015